{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:39:01Z","timestamp":1790386741640,"version":"4.1.0"},"reference-count":39,"publisher":"American Chemical Society (ACS)","issue":"2","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCYBJC28300"],"award-info":[{"award-number":["18JCYBJC28300"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21606041"],"award-info":[{"award-number":["21606041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21776044"],"award-info":[{"award-number":["21776044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51773098"],"award-info":[{"award-number":["51773098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nucleoside analogue drugs are widely used in cancer therapy and antiviral therapy, while fast metabolism, drug resistance, and severe side effects significantly limit their clinical applications. To address these issues, a variety of ester- and amide-linked prodrugs and their nanoparticulate formulations have been devised. However, most of these prodrugs suffer from inefficient transformation to native drugs in tumor. Here, we report an approach to conjugate gemcitabine, a kind of anticancer nucleoside drug and widely used to treat cancers, to polyketal backbone via pH-sensitive ketal linkage, and prepared gemcitabine-containing polyketal prodrug nanoparticles with minimal drug release under physiological conditions and acid-triggerable release of native gemcitabine. Intracellular and intratumoral degradation of the pH-sensitive gemcitabine-containing polyketal prodrug and incorporation of gemcitabine into DNA were confirmed by confocal microscopy using EdU, an analogue of gemcitabine. One single intravenous injection of these gemcitabine-containing polyketal prodrug nanoparticles demonstrated notable anticancer efficacy in the A2780 ovarian xenograft tumor model with increased survival rate and good safety. Our approach can be adopted for other diol nucleoside analogues to synthesize pH-sensitive nucleoside-polyketal prodrugs for developing anticancer and antiviral formulations.<\/jats:p>","DOI":"10.1021\/acs.biomac.9b01493","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T14:25:36Z","timestamp":1580307936000},"page":"803-814","source":"Crossref","is-referenced-by-count":36,"title":["Acid-Triggered Release of Native Gemcitabine Conjugated\nin Polyketal Nanoparticles for Enhanced Anticancer Therapy"],"prefix":"10.1021","volume":"21","author":[{"given":"Haiping","family":"Zhong","sequence":"first","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqing","family":"Mu","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Du","sequence":"additional","affiliation":[{"name":"Dalian Minzu University , , ,","place":["Dalian, China, 116600"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunkai","family":"Xu","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5645-6061","authenticated-orcid":true,"given":"Shubiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Dalian Minzu University , , ,","place":["Dalian, China, 116600"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-7451","authenticated-orcid":true,"given":"Shutao","family":"Guo","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"2026081416125799300_cit1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.leu.2402114","article-title":"Nucleoside\nanalogues: mechanisms\nof drug resistance and reversal strategies","volume":"15","author":"Galmarini","year":"2001","journal-title":"Leukemia"},{"key":"2026081416125799300_cit2","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside\/nucleotide\nanalogues in the treatment of chronic hepatitis B","volume":"66","author":"Fung","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"2026081416125799300_cit3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1021\/mp300370t","article-title":"Gemcitabine versus Modified Gemcitabine:\na review of several promising chemical modifications","volume":"10","author":"Moysan","year":"2013","journal-title":"Mol. Pharm."},{"key":"2026081416125799300_cit4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0090-9556(25)08805-1","article-title":"Metabolism and disposition\nof gemcitabine, and oncolytic\ndeoxycytidine analog, in mice, rats, and dogs","volume":"20","author":"Shipley","year":"1992","journal-title":"Drug Metab. Dispos."},{"key":"2026081416125799300_cit5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2006.06.7405","article-title":"Pharmacokinetics\nof Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine\nDeaminase Polymorphism","volume":"25","author":"Sugiyama","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"2026081416125799300_cit6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","article-title":"Pharmacokinetics\nand pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric\noncology: an EORTC-PAMM perspective","volume":"78","author":"Ciccolini","year":"2016","journal-title":"Cancer\nChemother. Pharmacol."},{"key":"2026081416125799300_cit7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2165\/11532970-000000000-00000","article-title":"Population\nPharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer\nPatients","volume":"49","author":"Sugiyama","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"2026081416125799300_cit8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s1040-8428(03)00119-7","article-title":"Gemcitabine:\ncurrent role and future options in the treatment of ovarian cancer","volume":"48","author":"Fruscella","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2026081416125799300_cit9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1021\/nn1034197","article-title":"Squalene based\nnanocomposites: a new platform for the design of multifunctional pharmaceutical\ntheragnostics","volume":"5","author":"Arias","year":"2011","journal-title":"ACS Nano"},{"key":"2026081416125799300_cit10","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1021\/acsnano.8b04205","article-title":"Stereocomplex Prodrugs\nof Oligo\u00ad(lactic acid) n-Gemcitabine in Poly\u00ad(ethylene glycol)- block-poly\u00ad(d,l-lactic\nacid) Micelles for Improved Physical Stability and Enhanced Antitumor\nEfficacy","volume":"12","author":"Tam","year":"2018","journal-title":"ACS Nano"},{"key":"2026081416125799300_cit11","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1021\/nl061942q","article-title":"Squalenoyl nanomedicines\nas potential therapeutics","volume":"6","author":"Couvreur","year":"2006","journal-title":"Nano Lett."},{"key":"2026081416125799300_cit12","doi-asserted-by":"publisher","first-page":"15678","DOI":"10.1038\/ncomms15678","article-title":"Conjugation of squalene\nto gemcitabine as unique approach exploiting endogenous lipoproteins\nfor drug delivery","volume":"8","author":"Sobot","year":"2017","journal-title":"Nat. Commun."},{"key":"2026081416125799300_cit13","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1021\/nn1034197","article-title":"Squalene Based\nNanocomposites: A New Platform for the Design of Multifunctional Pharmaceutical\nTheragnostics","volume":"5","author":"Arias","year":"2011","journal-title":"ACS Nano"},{"key":"2026081416125799300_cit14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jconrel.2004.09.001","article-title":"Preparation, characterization, cytotoxicity and pharmacokinetics\nof liposomes containing lipophilic gemcitabine prodrugs","volume":"100","author":"Immordino","year":"2004","journal-title":"J. Controlled Release"},{"key":"2026081416125799300_cit15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1021\/acsmacrolett.7b00160","article-title":"Development\nof a Gemcitabine-Polymer Conjugate with Prolonged Cytotoxicity against\na Pancreatic Cancer Cell Line","volume":"6","author":"Joubert","year":"2017","journal-title":"ACS Macro Lett."},{"key":"2026081416125799300_cit16","first-page":"4373","article-title":"Acid pH in tumors and\nits potential for therapeutic exploitation","volume":"49","author":"Tannock","year":"1989","journal-title":"Cancer Res."},{"key":"2026081416125799300_cit17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nmat3819","article-title":"A nanoparticle-based\nstrategy for the imaging of a broad range of\ntumours by nonlinear amplification of microenvironment signals","volume":"13","author":"Wang","year":"2013","journal-title":"Nat. Mater."},{"key":"2026081416125799300_cit18","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1038\/ncomms5712","article-title":"A smart\nand versatile theranostic nanomedicine platform\nbased on nanoporphyrin","volume":"5","author":"Li","year":"2014","journal-title":"Nat. Commun."},{"key":"2026081416125799300_cit19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1021\/bc049853x","article-title":"Acetals as pH-Sensitive\nLinkages for Drug Delivery","volume":"15","author":"Gillies","year":"2004","journal-title":"Bioconjugate Chem."},{"key":"2026081416125799300_cit20","doi-asserted-by":"publisher","first-page":"7978","DOI":"10.1021\/ja301710z","article-title":"Incorporation and Controlled Release\nof Silyl Ether Prodrugs from PRINT Nanoparticles","volume":"134","author":"Parrott","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"2026081416125799300_cit21","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1039\/c4md00150h","article-title":"A versatile acid-labile\nlinker for antibody\u2013drug\nconjugates","volume":"5","author":"Finniss","year":"2014","journal-title":"MedChemComm"},{"key":"2026081416125799300_cit22","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1021\/jacs.6b02435","article-title":"Extended Release\nof Native Drug Conjugated in Polyketal Microparticles","volume":"138","author":"Guo","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"2026081416125799300_cit23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jconrel.2012.08.017","article-title":"Polyacetal-stilbene\nconjugates - The first examples of polymer therapeutics for the inhibition\nof HIF-1 in the treatment of solid tumours","volume":"164","author":"England","year":"2012","journal-title":"J. Controlled Release"},{"key":"2026081416125799300_cit24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/ma062468d","article-title":"Novel in Situ\nForming, Degradable Dextran Hydrogels by Michael Addition Chemistry:\nSynthesis, Rheology, and Degradation","volume":"40","author":"Hiemstra","year":"2007","journal-title":"Macromolecules"},{"key":"2026081416125799300_cit25","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1021\/bc050176w","article-title":"Polyketal nanoparticles: a new pH-sensitive biodegradable\ndrug delivery vehicle","volume":"16","author":"Heffernan","year":"2005","journal-title":"Bioconjugate Chem."},{"key":"2026081416125799300_cit26","doi-asserted-by":"publisher","first-page":"10674","DOI":"10.1073\/pnas.1819889116","article-title":"Reprogramming the\nmicroenvironment with tumor-selective angiotensin blockers enhances\ncancer immunotherapy","volume":"116","author":"Chauhan","year":"2019","journal-title":"Proc. Natl. Acad. Sci.\nU.S.A."},{"key":"2026081416125799300_cit27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1021\/bc7004472","article-title":"Fully acid-degradable\nbiocompatible polyacetal microparticles for drug delivery","volume":"19","author":"Paramonov","year":"2008","journal-title":"Bioconjugate Chem."},{"key":"2026081416125799300_cit28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nmat2299","article-title":"Sustained release\nof a p38 inhibitor from non-inflammatory microspheres inhibits cardiac\ndysfunction","volume":"7","author":"Sy","year":"2008","journal-title":"Nat. Mater."},{"key":"2026081416125799300_cit29","doi-asserted-by":"publisher","first-page":"1800030","DOI":"10.1002\/adtp.201800030","article-title":"Stimuli-Responsive\nProdrug Chemistries for Drug Delivery","volume":"1","author":"Taresco","year":"2018","journal-title":"Adv.\nTher."},{"key":"2026081416125799300_cit30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/10611860400011885","article-title":"Polyacetal-diethylstilboestrol:\na polymeric drug designed for pH-triggered activation","volume":"12","author":"Vicent","year":"2004","journal-title":"J. Drug Targeting"},{"key":"2026081416125799300_cit31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jconrel.2011.12.035","article-title":"Demonstrating the\nimportance of polymer-conjugate\nconformation in solution on its therapeutic output: Diethylstilbestrol\n(DES)-polyacetals as prostate cancer treatment","volume":"159","author":"Gime\u0301nez","year":"2012","journal-title":"J. Controlled Release"},{"key":"2026081416125799300_cit32","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1039\/c4tb02133a","article-title":"Polyamidoamine and polyglycerol;\ntheir linear, dendritic and linear\u2013dendritic architectures\nas anticancer drug delivery systems","volume":"3","author":"Mohammadifar","year":"2015","journal-title":"J. Mater.\nChem. B"},{"key":"2026081416125799300_cit33","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1039\/c2cc36589h","article-title":"Acid-degradable\npolymers for drug delivery: a decade\nof innovation","volume":"49","author":"Binauld","year":"2013","journal-title":"Chem. Commun."},{"key":"2026081416125799300_cit34","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1021\/j100793a048","article-title":"Kinetics\nof the Acid-Catalyzed Hydrolysis of Acetal in Dimethyl Sulfoxide-Water\nSolvents at 15, 25, and 35\u00b0","volume":"68","author":"Wolford","year":"1964","journal-title":"J. Phys. Chem."},{"key":"2026081416125799300_cit35","first-page":"6075","article-title":"Equilibrative-sensitive\nnucleoside transporter and its role in gemcitabine sensitivity","volume":"60","author":"Rauchwerger","year":"2000","journal-title":"Cancer Res."},{"key":"2026081416125799300_cit36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jconrel.2014.06.038","article-title":"Insight into nanoparticle cellular uptake and intracellular\ntargeting","volume":"190","author":"Yameen","year":"2014","journal-title":"J. Controlled Release"},{"key":"2026081416125799300_cit37","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1073\/pnas.0712168105","article-title":"A chemical\nmethod for fast and sensitive detection\nof DNA synthesis in vivo","volume":"105","author":"Salic","year":"2008","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."},{"key":"2026081416125799300_cit38","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1158\/0008-5472.can-05-4203","article-title":"Transcription\nanalysis of human equilibrative\nnucleoside transporter-1 predicts survival in pancreas cancer patients\ntreated with gemcitabine","volume":"66","author":"Giovannetti","year":"2006","journal-title":"Cancer Res."},{"key":"2026081416125799300_cit39","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/s0300-2977(00)00029-2","article-title":"Severe acute lung injury\ninduced by gemcitabine","volume":"56","author":"Linskens","year":"2000","journal-title":"Neth. J. Med."}],"container-title":["Biomacromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.biomac.9b01493","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article-pdf\/21\/2\/803\/5927720\/bm9b01493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article-pdf\/21\/2\/803\/5927720\/bm9b01493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:24:57Z","timestamp":1786739097000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article\/21\/2\/803\/591822\/Acid-Triggered-Release-of-Native-Gemcitabine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,1,29]]},"published-print":{"date-parts":[[2020,2,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.biomac.9b01493","relation":{},"ISSN":["1525-7797","1526-4602"],"issn-type":[{"value":"1525-7797","type":"print"},{"value":"1526-4602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}